Michael Groves, a resident of Ottawa, had no inkling that he was facing a life-threatening illness when he first sought medical attention in January 2021. Initially believing he had appendicitis due to severe abdominal pain, medical staff quickly ruled this out, sending him home with no further concerns. However, just days later, Groves discovered blood in his stool and promptly consulted his family doctor, who scheduled him for a colonoscopy in April of that year. What followed was a shocking diagnosis: a five-centimetre tumour indicating Stage 3 colorectal cancer that had already spread to two lymph nodes.
Early Detection: A Life-Saving Necessity
Groves, now 54, reflects on the devastating news he received with disbelief. “The shock was just, like, wow, just devastating,” he recounted. At the time of his diagnosis, he had been leading an active lifestyle, feeling fit enough to complete a 5K run shortly before. His experience underscores a growing concern among healthcare advocates about the rising incidence of colorectal cancer in individuals under the age of 50.
Recent advocacy from the Canadian Cancer Society highlights this urgent issue, calling for provinces and territories to lower the recommended age for colorectal cancer screening from 50 to 45. The society points out that individuals under 50 are now 2 to 2.5 times more likely to receive a colorectal cancer diagnosis compared to previous generations. As Brandon Purcell, advocacy manager for prevention and early detection at the Canadian Cancer Society, stated, “That growth is something that’s very concerning for us, and we think that it’s time for governments to react to that so that we can catch more of these cancers early.”
Current Screening Practices
Under current guidelines, individuals aged 50 and older are eligible for a fecal immunochemical test (FIT), which involves collecting a stool sample at home and sending it to a lab for analysis. If blood is detected in the sample, the individual is referred for a colonoscopy to further investigate. However, those under 50 with certain risk factors—such as a family history of colorectal cancer or visible symptoms—may still be referred for earlier screenings.
Advocates argue that expanding the eligibility for FIT testing to include those aged 45 and older could significantly improve early detection rates. According to the Canadian Cancer Society, when colorectal cancer is diagnosed at earlier stages, survival rates can reach as high as 90%. In stark contrast, if the cancer is detected at advanced stages, the survival rate plummets to less than 15%.
The Case for Change
Colorectal Cancer Canada, led by president and CEO Barry Stein, echoes the call for a shift in screening guidelines, emphasising the importance of early detection in preventing cancer progression. Colonoscopies not only detect tumours but can also identify and remove precancerous polyps before they develop into cancer. Stein explained, “It takes eight to ten years for a polyp to develop into cancer,” underscoring the critical window for intervention that regular screenings could provide.
Both the Canadian Cancer Society and Colorectal Cancer Canada refer to a recent modelling study published in the Journal of the Canadian Association of Gastroenterology, which supports their advocacy. This study estimated that initiating home-based FIT testing at age 45 could prevent 15,070 colorectal cancer cases and 6,100 deaths over the next 45 years. Additionally, it projected potential savings of $233 million in cancer treatment costs, even after factoring in the expenses related to increased screening.
Why it Matters
The call for earlier colorectal cancer screenings is more than just a matter of policy; it represents a crucial shift in how we approach health and wellness in our communities. With the alarming rise in diagnoses among younger adults, it is imperative that we adapt our healthcare strategies to prioritise early detection. By lowering the screening age, we could not only save lives but also reduce the financial burden on the healthcare system. Ultimately, proactive measures in screening can lead to healthier outcomes for future generations, making it essential for policymakers to take action now.
